DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
Dr. Doris Wethers, 91, on Front Lines against Sickle Cell, Dies
Dr. Doris L. Wethers, who broke racial barriers in the medical world before gaining renown for research and advocacy that helped lead to mandatory testing of all newborns for sickle cell anemia, died on Jan. 28 in Yonkers. She was 91.
The cause was complications of a stroke, her daughter-in-law Lisa Booker said.
In 1965, Dr. Wethers became the first black chief of a medical department at a New York City voluntary, or private nonprofit, hospital when she was named director of pediatrics at Knickerbocker Hospital in West Harlem.
Knickerbocker, which had a history of refusing to admit black patients, was renamed Arthur C. Logan Memorial Hospital before it closed in 1979.
+myBinderRelated Content
-
education & researchFeasibility and acceptability of internet-delivered cognitive behavioral therapy for chronic pain in adolescents wit...Pain is a clinical hallmark of sickle ce...
-
education & researchFirst Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities?BACKGROUND AND PURPOSE: There is little ...
-
news & eventsHow sickled red blood cells stick to blood vesselsOne of the most common complications o...
-
news & eventsGBT expands sickle cell disease pipeline with worldwide licensing agreement for inclacumab for the treatment of vaso...Global Blood Therapeutics, Inc...
-
news & eventsSCA Therapy Hydroxyurea Doesn’t Boost Malaria Risk in Sub-Saharan Africa, Study FindsHydroxyurea, a treatment recommended for...
-
news & eventsVirtual Reality Helps Reduce Pain Among Patients With Sickle Cell DiseaseImmersive virtual reality appeared effec...
-
news & eventsSickle Cell Disease Association of America, Inc. Names New CEO & PresidentThe Sickle Cell Disease Association of A...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.